胰岛素抵抗替代指标与2型糖尿病合并骨质疏松的相关性研究
The Correlation between Insulin Resistance Replacement Index and Osteoporosis in Type 2 Diabetes Mellitus
摘要: 目的:探讨2型糖尿病患者胰岛素抵抗替代指标(甘油三酯–葡萄糖指数和胰岛素抵抗代谢评分)与骨质疏松严重程度的相关性研究。方法:纳入387例T2DM患者,根据骨密度分为骨密度正常组(135例)、低骨量组(164例)和骨质疏松组(88例)。收集患者的一般资料和骨密度值,计算甘油三酯–葡萄糖指数(TyG)、胰岛素抵抗代谢评分(METS-IR)。采用单因素与多因素logistic回归方法分析TyG、METS-IR与骨密度之间的关系。结果:合并OP组、低骨量组METSIR、TyG均高于骨密度正常组;合并OP组METS-IR、TyG高于低骨量组;METS-IR、TyG与糖尿病发生骨质疏松的疾病进展呈正相关(p < 0.05);METS-IR、TyG是2型糖尿病合并骨质疏松的独立影响因素(均p < 0.05)。结论:患者胰岛素抵抗程度越高,患骨质疏松症的风险就越大。
Abstract: Objective: To investigate the correlation between insulin resistance replacement indexes (triglyceride-glucose index and insulin resistance metabolic score) and the severity of osteoporosis in patients with type 2 diabetes. Methods: 387 T2DM patients were included and divided into normal bone mineral density group (135 cases), low bone mass group (164 cases) and osteoporosis group (88 cases) according to BMD. General data and bone mineral density were collected, and triglyceride-glucose index (TyG) and insulin resistance metabolic score (METS-IR) were calculated. Univariate and multivariate logistic regression methods were used to analyze the relationship between TyG, MET-IR and bone mineral density. Results: METSIR and TyG in OP group and low bone mass group were higher than those in normal bone density group. METS-IR and TyG in OP group were higher than those in low bone mass group. METS-IR and TyG were positively correlated with the disease progression of osteoporosis caused by diabetes (p < 0.05); METS-IR and TyG were independent factors of type 2 diabetes mellitus combined with osteoporosis (all p < 0.05). Conclusion: The higher the degree of insulin resistance, the greater the risk of osteoporosis.
文章引用:吴雪, 杨振兴, 韩娇娇, 董幼平. 胰岛素抵抗替代指标与2型糖尿病合并骨质疏松的相关性研究[J]. 临床医学进展, 2025, 15(2): 1620-1626. https://doi.org/10.12677/acm.2025.152518

参考文献

[1] Compston, J.E., McClung, M.R. and Leslie, W.D. (2019) Osteoporosis. The Lancet, 393, 364-376. [Google Scholar] [CrossRef] [PubMed]
[2] Oei, L., Rivadeneira, F., Zillikens, M.C. and Oei, E.H.G. (2015) Diabetes, Diabetic Complications, and Fracture Risk. Current Osteoporosis Reports, 13, 106-115. [Google Scholar] [CrossRef] [PubMed]
[3] Shanbhogue, V.V., Mitchell, D.M., Rosen, C.J. and Bouxsein, M.L. (2016) Type 2 Diabetes and the Skeleton: New Insights into Sweet Bones. The Lancet Diabetes & Endocrinology, 4, 159-173. [Google Scholar] [CrossRef] [PubMed]
[4] Cersosimo, E., Solis-Herrera, C., Trautmann, M., Malloy, J. and Triplitt, C. (2014) Assessment of Pancreatic β-Cell Function: Review of Methods and Clinical Applications. Current Diabetes Reviews, 10, 2-42. [Google Scholar] [CrossRef] [PubMed]
[5] Bello-Chavolla, O.Y., Almeda-Valdes, P., Gomez-Velasco, D., Viveros-Ruiz, T., Cruz-Bautista, I., Romo-Romo, A., et al. (2018) METS-IR, a Novel Score to Evaluate Insulin Sensitivity, Is Predictive of Visceral Adiposity and Incident Type 2 Diabetes. European Journal of Endocrinology, 178, 533-544. [Google Scholar] [CrossRef] [PubMed]
[6] Borai, A., Livingstone, C. and Ferns, G.A.A. (2007) The Biochemical Assessment of Insulin Resistance. Annals of Clinical Biochemistry: International Journal of Laboratory Medicine, 44, 324-342. [Google Scholar] [CrossRef] [PubMed]
[7] Simental-Mendía, L.E., Rodríguez-Morán, M. and Guerrero-Romero, F. (2008) The Product of Fasting Glucose and Triglycerides as Surrogate for Identifying Insulin Resistance in Apparently Healthy Subjects. Metabolic Syndrome and Related Disorders, 6, 299-304. [Google Scholar] [CrossRef] [PubMed]
[8] Ahn, S.H., Kim, H., Kim, B., Lee, S.H. and Koh, J. (2015) Insulin Resistance and Composite Indices of Femoral Neck Strength in Asians: The Fourth Korea National Health and Nutrition Examination Survey (KNHANES IV). Clinical Endocrinology, 84, 185-193. [Google Scholar] [CrossRef] [PubMed]
[9] Park, H.T., Cho, G.J., Ahn, K.H., Shin, J.H., Hong, S.C., Kim, T., et al. (2009) Thyroid Stimulating Hormone Is Associated with Metabolic Syndrome in Euthyroid Postmenopausal Women. Maturitas, 62, 301-305. [Google Scholar] [CrossRef] [PubMed]
[10] Shah, V.N., Sippl, R., Joshee, P., Pyle, L., Kohrt, W.M., Schauer, I.E., et al. (2017) Trabecular Bone Quality Is Lower in Adults with Type 1 Diabetes and Is Negatively Associated with Insulin Resistance. Osteoporosis International, 29, 733-739. [Google Scholar] [CrossRef] [PubMed]
[11] Ahmad, O.S., Leong, A., Miller, J.A., Morris, J.A., Forgetta, V., Mujammami, M., et al. (2016) A Mendelian Randomization Study of the Effect of Type-2 Diabetes and Glycemic Traits on Bone Mineral Density. Journal of Bone and Mineral Research, 32, 1072-1081. [Google Scholar] [CrossRef] [PubMed]
[12] 中华医学会糖尿病学分会. 中国2型糖尿病防治指南(2020年版) [J]. 中华内分泌代谢杂志, 2021, 37(4): 311-398.
[13] Professor Kanis, J.A., Melton, L.J., Christiansen, C., Johnston, C.C. and Khaltaev, N. (1994) The Diagnosis of Osteoporosis. Journal of Bone and Mineral Research, 9, 1137-1141. [Google Scholar] [CrossRef] [PubMed]
[14] Hu, L., Zeng, X., Wei, X., Wang, H., Wu, Y., Gu, W., et al. (2020) Interface Engineering for Enhancing Electrocatalytic Oxygen Evolution of NiFe LDH/NiTe Heterostructures. Applied Catalysis B: Environmental, 273, Article 119014. [Google Scholar] [CrossRef
[15] Napoli, N., Conte, C., Pedone, C., Strotmeyer, E.S., Barbour, K.E., Black, D.M., et al. (2019) Effect of Insulin Resistance on BMD and Fracture Risk in Older Adults. The Journal of Clinical Endocrinology & Metabolism, 104, 3303-3310. [Google Scholar] [CrossRef] [PubMed]
[16] Fornari, R., Marocco, C., Francomano, D., Fittipaldi, S., Lubrano, C., Bimonte, V.M., et al. (2017) Insulin Growth Factor-1 Correlates with Higher Bone Mineral Density and Lower Inflammation Status in Obese Adult Subjects. Eating and Weight Disorders-Studies on Anorexia, Bulimia and Obesity, 23, 375-381. [Google Scholar] [CrossRef] [PubMed]
[17] Arikan, S., Tuzcu, A., Bahceci, M., Ozmen, S. and Gokalp, D. (2012) Insulin Resistance in Type 2 Diabetes Mellitus May Be Related to Bone Mineral Density. Journal of Clinical Densitometry, 15, 186-190. [Google Scholar] [CrossRef] [PubMed]
[18] Tonks, K.T., White, C.P., Center, J.R., Samocha-Bonet, D. and Greenfield, J.R. (2017) Bone Turnover Is Suppressed in Insulin Resistance, Independent of Adiposity. The Journal of Clinical Endocrinology & Metabolism, 102, 1112-1121. [Google Scholar] [CrossRef] [PubMed]
[19] Mesinovic, J., McMillan, L.B., Shore‐Lorenti, C., Zengin, A., De Courten, B., Ebeling, P.R., et al. (2019) Sex‐Specific Associations between Insulin Resistance and Bone Parameters in Overweight and Obese Older Adults. Clinical Endocrinology, 90, 680-689. [Google Scholar] [CrossRef] [PubMed]
[20] Lee, H.S. and Hwang, J.S. (2020) Impact of Type 2 Diabetes Mellitus and Antidiabetic Medications on Bone Metabolism. Current Diabetes Reports, 20, Article No. 78. [Google Scholar] [CrossRef] [PubMed]